SEC Form 4 · accession 0001179110-16-030655
RIGEL PHARMACEUTICALS INC · RIGL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eldon C. Mayer III
Officer — EVP &Chief Commercial Officer
Period of report
Oct 10, 2016
Accepted (ET)
Oct 11, 2016 · 8:44 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001034842
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $3.92 | Oct 10, 2016 | A | 300,000 | A | — | Oct 10, 2026 | Common Stock | 300,000 | 300,000 | D |
Explanation of responses
- F1Common Stock subject to the Option shall vest over a four-year term, with one-fourth of the shares subject to the Option vesting on October 10, 2017, and 1/48th of the shares subject to the Option vesting monthly thereafter, subject to the Continuous Service (as defined in the Plan) to the Company through each vesting date.